1. Home
  2. PGEN vs AEYE Comparison

PGEN vs AEYE Comparison

Compare PGEN & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.36

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo AudioEye Inc.

AEYE

AudioEye Inc.

HOLD

Current Price

$7.75

Market Cap

91.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
AEYE
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
91.0M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
PGEN
AEYE
Price
$4.36
$7.75
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$8.33
$14.63
AVG Volume (30 Days)
3.3M
120.1K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.56
EPS
N/A
N/A
Revenue
$230,981,000.00
$40,311,000.00
Revenue This Year
$1,115.92
$11.12
Revenue Next Year
$81.04
$11.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.52
52 Week Low
$1.28
$5.31
52 Week High
$5.47
$16.39

Technical Indicators

Market Signals
Indicator
PGEN
AEYE
Relative Strength Index (RSI) 55.30 58.81
Support Level $3.96 $6.09
Resistance Level $4.40 $8.20
Average True Range (ATR) 0.27 0.51
MACD 0.01 0.00
Stochastic Oscillator 46.74 85.75

Price Performance

Historical Comparison
PGEN
AEYE

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.

Share on Social Networks: